Zhejiang Hisun Pharmaceutical Co., Ltd. Class ASSE: 600267

Announcement on Progress in Capital Increase and Debt-to-Share Swap Matters of Zhejiang Dtrm BioPharma Co., Ltd.

· Issued by Zhejiang Hisun Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Progress in Capital Increase and Debt-to-Share Swap Matters of Zhejiang Dtrm BioPharma Co., Ltd.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment